fax: +49 511 532-4896
Version of Record online: 15 FEB 2013
Copyright © 2012 American Association for the Study of Liver Diseases
Volume 57, Issue 5, pages 1716–1724, May 2013
How to Cite
Westhaus, S., Bankwitz, D., Ernst, S., Rohrmann, K., Wappler, I., Agné, C., Luchtefeld, M., Schieffer, B., Sarrazin, C., Manns, M. P., Pietschmann, T., Ciesek, S. and von Hahn, T. (2013), Characterization of the inhibition of hepatitis C virus entry by In vitro–generated and patient-derived oxidized low-density lipoprotein. Hepatology, 57: 1716–1724. doi: 10.1002/hep.26190
Potential conflict of interest: Dr. Manns is on the speakers' bureau of, consults for, and received grants from Roche, Gilead, Bristol-Myers Squibb, Merck, and Janssen. He is also on the speakers' bureau of GlaxoSmithKline. He consults for, and received grants from, Novartis and Boehringer-Ingelheim. He consults for Tibotec and Vertex. Dr. Pietschmann consults for Biotest and Janssen. Dr. Ciesek is on the speakers' bureau of MSD and received grants from Novartis.
This study was funded by the DFG Emmy Noether Program (grant no.: HA 4393/2-1; to T.v.H.) as well as SFB900 (project A6) and a grant from the Initiative and Networking Fund of the Helmholtz Association (grant no.: SO-024; to T.P.) and a DFG grant (no. Ci 171/2-1; to S.C.). The authors thank Jens Bukh (University of Copenhagen, Denmark), Alfredo Nicosia (Okairos, Basel, Switzerland), and Charlie Rice (The Rockefeller University, New York, NY) for providing reagents and Heiner Wedemeyer and the HepNet serum Bank for providing sera.
- Issue online: 22 APR 2013
- Version of Record online: 15 FEB 2013
- Accepted manuscript online: 5 DEC 2012 02:52AM EST
- Manuscript Accepted: 15 NOV 2012
- Manuscript Revised: 14 NOV 2012
- Manuscript Received: 25 JUN 2012
Additional Supporting Information may be found in the online version of this article.
|HEP_26190_sm_SuppFig1.tif||6609K||Supporting Information Figure 1.|
|HEP_26190_sm_SuppFig2.tif||6609K||Supporting Information Figure 2.|
|HEP_26190_sm_SuppFig3.tif||6609K||Supporting Information Figure 3.|
|HEP_26190_sm_SuppFig4.tif||6611K||Supporting Information Figure 4.|
|HEP_26190_sm_SuppFig5.tif||6609K||Supporting Information Figure 5.|
|HEP_26190_sm_SuppTable1.doc||35K||Supporting Information Table 1.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.